![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.A.B., G.D., R.L.); Division of Biochemistry and Molecular Biology, University of Glasgow, Glasgow, United Kingdom (J.J.C., J.F.L.-G., G.M.); Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina (R.G.B.); and School of Animal and Microbial Sciences, University of Reading, Whiteknights, Reading, United Kingdom (P.G.S.)
G-protein-coupled receptors (GPCRs) represent the largest family of receptors involved in transmembrane signaling. Although these receptors were generally believed to be monomeric entities, accumulating evidence supports the presence of GPCRs in multimeric forms. Here, using immunoprecipitation as well as time-resolved fluorescence resonance energy transfer to assess protein-protein interactions in living cells, we unambiguously demonstrate the occurrence of dimerization of the human histamine H1 receptor. We also show the presence of domain-swapped H1 receptor dimers in which there is the reciprocal exchange of transmembrane domain TM domains 6 and 7 between the receptors present in the dimer. Mutation of aspartate107 in transmembrane (TM) 3 or phenylalanine432 in TM6 to alanine results in two radioligand-binding-deficient mutant H1 receptors. Coexpression of H1D107 A and H1F432A, however, results in a reconstituted radioligand binding site that exhibits a pharmacological profile that corresponds to the wild-type H1 receptor. Interestingly, the H1 receptor radioligands [3H]mepyramine and [3H]-()-trans-1-phenyl-3-N,N-dimethylamino-1,2,3,4-tetrahydronaphthalene show differential saturation binding values (Bmax) for wild-type H1 receptors but not for the radioligand binding site that is formed upon coexpression of H1 D107A and H1 F432A receptors, suggesting the presence of different H1 receptor populations.
Address correspondence to: Dr. Rob Leurs, Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The Netherlands. E-mail: leurs{at}few.vu.nl
This article has been cited by other articles:
![]() |
K. Fuxe, D. Marcellino, D. Guidolin, A. S. Woods, and L. F. Agnati Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors Physiology, December 1, 2008; 23(6): 322 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Noubade, N. Saligrama, K. Spach, R. del Rio, E. P. Blankenhorn, T. Kantidakis, G. Milligan, M. Rincon, and C. Teuscher Autoimmune Disease-Associated Histamine Receptor H1 Alleles Exhibit Differential Protein Trafficking and Cell Surface Expression J. Immunol., June 1, 2008; 180(11): 7471 - 7479. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Szidonya, M. Cserzo, and L. Hunyady Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions J. Endocrinol., March 1, 2008; 196(3): 435 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Egerod, B. Holst, P. S. Petersen, J. B. Hansen, J. Mulder, T. Hokfelt, and T. W. Schwartz GPR39 Splice Variants Versus Antisense Gene LYPD1: Expression and Regulation in Gastrointestinal Tract, Endocrine Pancreas, Liver, and White Adipose Tissue Mol. Endocrinol., July 1, 2007; 21(7): 1685 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. van Rijn, P. L. Chazot, F. C. Shenton, K. Sansuk, R. A. Bakker, and R. Leurs Oligomerization of Recombinant and Endogenously Expressed Human Histamine H4 Receptors Mol. Pharmacol., August 1, 2006; 70(2): 604 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bakker, A. F. Lozada, A. van Marle, F. C. Shenton, G. Drutel, K. Karlstedt, M. Hoffmann, M. Lintunen, Y. Yamamoto, R. M. van Rijn, et al. Discovery of Naturally Occurring Splice Variants of the Rat Histamine H3 Receptor That Act as Dominant-Negative Isoforms Mol. Pharmacol., April 1, 2006; 69(4): 1194 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pascal and G. Milligan Functional Complementation and the Analysis of Opioid Receptor Homodimerization Mol. Pharmacol., September 1, 2005; 68(3): 905 - 915. [Abstract] [Full Text] [PDF] |
||||